Upexi (NASDAQ:UPXI) CEO Allan Marshall Purchases 50,000 Shares of Stock

Upexi, Inc. (NASDAQ:UPXI) CEO Allan Marshall acquired 50,000 shares of Upexi stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $2.07 per share, with a total value of $103,500.00. Following the completion of the purchase, the chief executive officer owned 3,996,261 shares of the company’s stock, valued at approximately $8,272,260.27. The trade was a 1.27% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Allan Marshall also recently made the following trade(s):

• On Monday, December 15th, Allan Marshall bought 100,000 shares of Upexi stock. The stock was purchased at an average price of $2.07 per share, for a total transaction of $207,000.00.

Upexi Stock Performance

UPXI traded up $0.15 during trading on Thursday, reaching $2.02. 1,620,039 shares of the company’s stock were exchanged, compared to its average volume of 4,136,309. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.41 and a quick ratio of 3.39. Upexi, Inc. has a 1 year low of $1.86 and a 1 year high of $22.57. The company’s fifty day simple moving average is $3.69 and its 200-day simple moving average is $5.73. The stock has a market capitalization of $127.37 million, a P/E ratio of -0.47 and a beta of -0.52.

Upexi (NASDAQ:UPXI) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.11). Upexi had a negative return on equity of 30.42% and a net margin of 264.25%.The business had revenue of $9.24 million during the quarter, compared to analyst estimates of $7.33 million.

Upexi declared that its board has authorized a share buyback plan on Thursday, November 13th that authorizes the company to buyback $50.00 million in shares. This buyback authorization authorizes the company to buy up to 25.1% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On Upexi

A number of hedge funds have recently bought and sold shares of the business. Kathmere Capital Management LLC acquired a new position in shares of Upexi during the 2nd quarter worth approximately $6,535,000. NewGen Equity Long Short Fund purchased a new stake in Upexi in the 2nd quarter worth $1,720,000. NewGen Asset Management Ltd purchased a new stake in Upexi in the 2nd quarter worth $1,720,000. Millington Financial Advisors LLC acquired a new position in Upexi during the second quarter worth $60,000. Finally, North Star Investment Management Corp. purchased a new position in Upexi during the second quarter valued at $45,000. Hedge funds and other institutional investors own 5.68% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on UPXI. Wall Street Zen upgraded Upexi from a “sell” rating to a “hold” rating in a research note on Tuesday. Cantor Fitzgerald lowered their price objective on Upexi from $16.00 to $6.00 and set an “overweight” rating on the stock in a research report on Friday, November 14th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Upexi in a research note on Monday. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $10.50.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.